Therapeutic warming: treatment and evidence discussion
======================================================

Yenra | Prepared September 19, 2026
Companion guide: https://yenra.com/warming-device/

Complete with the treating clinician before deciding about a proposed treatment. This is a discussion aid, not a home-treatment or device-use instruction. Do not begin diathermy while implant compatibility or another safety question is unresolved. Keep health details privately.

Keep the completed record privately. This file has no form submission or data collection.

1. Date, treating clinician and condition being assessed:
   ____________________________________________________________

2. Exact treatment name: superficial heat / shortwave diathermy / other:
   ____________________________________________________________

3. Device and mode proposed, identified by the clinician:
   ____________________________________________________________

4. Goal in a named daily activity and starting difficulty:
   ____________________________________________________________

5. Evidence or guideline relevant to this condition and treatment:
   ____________________________________________________________

6. Reason to choose this option and reasonable alternatives:
   ____________________________________________________________

7. Implants, retained leads and device identification details disclosed:
   ____________________________________________________________

8. Pregnancy, altered sensation, circulation, skin or other health concerns disclosed:
   ____________________________________________________________

9. Who has completed the applicable safety screening:
   ____________________________________________________________

10. Expected benefit, review date and criteria for changing or stopping the plan:
   ____________________________________________________________

11. Risks, symptoms to report and contact route:
   ____________________________________________________________

12. How this fits exercise or the wider rehabilitation plan:
   ____________________________________________________________

13. Costs, appointments and questions still unanswered:
   ____________________________________________________________

Source context: use the companion guide and the following primary references to clarify terminology. The responsible team must check current instructions and evidence for the exact equipment or treatment.
https://www.accessdata.fda.gov/cdrh_docs/pdf2/K020227.pdf
https://staging.federallabs.org/flc-highlights/awards/body-friendly-rf-diathermy-system-90e3a6e518e1ebb4823302e64325f1f8
https://www.nice.org.uk/guidance/NG226/chapter/recommendations
https://www.medtronic.com/en-us/l/isw/spinal-cord-stimulation-indications-safety-warnings.html
https://www.medtronic.com/in-en/patients/treatments-therapies/neurostimulator-overactive-bladder/important-safety-information/product-advisories.html